| 10:30 -
12:00 |
Anadolu |
Sponsored
Symposium 3 (Organon) NuvaRing® — From Science to Satisfaction |
|
|
Chair: C. Benedetto (Italy), Co-chair: B.
Oddens (The Netherlands) |
|
10:30 • SS3-01 |
Scientific backbone – paradigm
shift from dose to exposure E. Ng (USA) |
|
10:55 • SS3-02 |
A balancing act – I. Milsom (Sweden) |
|
11:20 • SS3-03 |
Providing a logical choice for your
patient – R. Nappi (Italy) |
|
|
|
| 10:30 -
12:00 |
Marmara |
Session
4 (State of the Art) Attitudes to contraception |
|
|
Chair: T. Sener (Turkey), Co-chair: A.
Yeshaya (Israel) |
|
10:30 • IS-17 |
Religion and traditions – B.
Dilbaz (Turkey) |
|
10:50 • IS-18 |
Media issues, educational framework
– D. Apter (Finland) |
|
11:10 • IS-19 |
Educational and legal framework –
G. Lazdane (WHO) |
|
|
Free communications |
|
11:30 • FC-28 |
University student men’s views,
attitudes and behaviours about family planning and emergency
contraception – H. Sahin (Turkey) |
|
11:45 • FC-29 |
Reproductive Health Education of
Conscripts Armed Forces: First Evaluation of Training Courses. (in
Turkish) S. Gungor (Turkey) |
|
|
|
| 10:30 -
12:00 |
Dolmabahçe |
Free
Communication Session 4 |
|
|
Chair: A. Bigrigg (UK), Co-chair: D.
Rebelo (Portugal) |
|
10:30 • FC-30 |
The Challenges of Unprotected Sex:
Statistical Analysis of a Global Sex Survey – M.B.F. Fontes (USA) |
|
10:43 • FC-31 |
Significant improvement in
cycle-related symptoms following treatment with continuous LNG/EE, a
low-dose continuous oral contraceptive. – E.W. Freeman (USA) |
|
10:56 • FC-32 |
Prevalence of bacterial vaginosis and
relationship with personal hygiene in Turkish women using an IUD –
I. Gonenc (Turkey) |
|
11:09 • FC-33 |
Identification of novel endometrial
targets for contraception using microarray technology – S. Mirkin
(USA) |
|
11:22 • FC-34 |
Evaluation of the benefits of a new
hysteroscopic sterilisation (Essure®) on the OPD. – M.P.H.
Vleugels (The Netherlands) |
|
11:35 • FC-35 |
Ease and safety of insertion,
contraceptive performance and effect on menstrual blood loss of a new
LNG-IUS, FemilisTM, in parous and nulliparous women – D.
Wildemeersch (Belgium) |
|
11:48 • FC-36 |
The poor knowledge on contraceptive
methods is major cause of induced abortion leading to infectious
abortion in women of west areas in Iran – R. Ahmadi (Iran) |
|
|
|
| 10:30 -
12:00 |
Topkapi
A |
European
Society for Human Reproduction and Embryology (ESHRE) |
|
|
Hormonal
contraception and cardiovascular risk |
|
|
Chair: P.G. Crosignani (Italy), Co-chair:
D. Cibula (Czech Rep.) |
|
10:30 |
Coronary heart and cardiovascular
disease – C. La Vecchia (Italy) |
|
11:00 |
The metabolic syndrome – A. J.
Goverde (The Netherlands) |
|
11:30 |
Hormonal contraception in PCO patients
– D. Cibula (Czech Rep.) |
|
|
|
